A detailed history of Federated Hermes, Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,282,696 shares of ABCL stock, worth $6.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,282,696
Previous 2,726,016 16.26%
Holding current value
$6.67 Million
Previous $8.07 Million 26.73%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.39 - $3.49 $1.06 Million - $1.55 Million
-443,320 Reduced 16.26%
2,282,696 $5.91 Million
Q2 2024

Aug 08, 2024

SELL
$2.73 - $4.73 $244,179 - $423,065
-89,443 Reduced 3.18%
2,726,016 $8.07 Million
Q1 2024

May 14, 2024

SELL
$4.29 - $5.97 $1.3 Million - $1.8 Million
-302,221 Reduced 9.69%
2,815,459 $12.8 Million
Q4 2023

Jan 31, 2024

SELL
$3.91 - $5.93 $534,391 - $810,470
-136,673 Reduced 4.2%
3,117,680 $17.8 Million
Q3 2023

Nov 13, 2023

SELL
$4.6 - $7.95 $550,629 - $951,630
-119,702 Reduced 3.55%
3,254,353 $15 Million
Q2 2023

Aug 14, 2023

BUY
$5.66 - $7.59 $2.66 Million - $3.57 Million
469,796 Added 16.18%
3,374,055 $21.8 Million
Q1 2023

May 08, 2023

BUY
$7.31 - $11.18 $2.79 Million - $4.27 Million
381,937 Added 15.14%
2,904,259 $21.9 Million
Q4 2022

Feb 13, 2023

BUY
$9.48 - $14.52 $3.97 Million - $6.07 Million
418,281 Added 19.88%
2,522,322 $25.6 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $3.38 Million - $5.03 Million
367,822 Added 21.19%
2,104,041 $20.8 Million
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $2.56 Million - $4.77 Million
448,219 Added 34.8%
1,736,219 $18.5 Million
Q1 2022

May 13, 2022

BUY
$7.46 - $14.14 $3.43 Million - $6.51 Million
460,153 Added 55.58%
1,288,000 $12.6 Million
Q4 2021

Feb 14, 2022

BUY
$12.99 - $17.73 $3.09 Million - $4.22 Million
237,847 Added 40.31%
827,847 $11.8 Million
Q3 2021

Nov 15, 2021

BUY
$14.85 - $21.34 $2.88 Million - $4.14 Million
194,000 Added 48.99%
590,000 $11.8 Million
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $6.99 Million - $11.8 Million
346,000 Added 692.0%
396,000 $8.71 Million
Q4 2020

Feb 12, 2021

BUY
$39.0 - $58.9 $1.95 Million - $2.95 Million
50,000 New
50,000 $2.01 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.